Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248577 Methods and compositions for administering stem cells
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007US20070248570 Pharmaceutical Compositions Containing Platinum Complexes with Secondary Xanthates and Therapeutic Uses Thereof
10/25/2007US20070248538 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/25/2007CA2649836A1 Calixarene derivatives as anticancer agent
10/25/2007CA2649710A1 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
10/25/2007CA2649326A1 Targeted binding agents directed to upar and uses thereof
10/25/2007CA2649324A1 4, 5-dihydro-[1,2,4] triazolo [4,3f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders
10/25/2007CA2649302A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007CA2649288A1 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
10/25/2007CA2649287A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007CA2649269A1 Protein complex and process for producing the same
10/25/2007CA2649207A1 Magnetic nanoparticles compositions and uses thereof
10/25/2007CA2649146A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007CA2649013A1 Her-2/neu multi-peptide vaccine
10/25/2007CA2648216A1 Tetrahalogenated compounds useful as inhibitors of angiogenesis
10/25/2007CA2648207A1 Thiophene-carboxamides useful as inhibitors of protein kinases
10/25/2007CA2648196A1 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders
10/25/2007CA2647243A1 Dihydrothienopyrimidine for treating inflammatory disorders
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847602A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847539A1 Quinazoline derivatives
10/24/2007EP1847534A2 Thiadiazoline derivative
10/24/2007EP1847273A1 April receptor (BCMA) and uses thereof
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846558A2 Inhibiting her2 shedding with matrix metalloprotease antagonists
10/24/2007EP1846441A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof
10/24/2007EP1846437A1 ACID ADDITION SALTS OF Ac-PHSCN-NH2
10/24/2007EP1846424A1 Proteasome inhibitors and methods of using the same
10/24/2007EP1846408A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
10/24/2007EP1846406A1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
10/24/2007EP1846404A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
10/24/2007EP1846402A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases
10/24/2007EP1846399A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
10/24/2007EP1846395A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
10/24/2007EP1846394A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/24/2007EP1846393A2 4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
10/24/2007EP1846391A2 Raf inhibitor compounds and methods
10/24/2007EP1846373A2 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
10/24/2007EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
10/24/2007EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
10/24/2007EP1846039A2 Targeted chimeric molecules for cancer therapy
10/24/2007EP1846020A2 Methods for treating renal cell carcinoma
10/24/2007EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide
10/24/2007EP1845997A2 Apoptosis-inducing antineoplastic silver (i) coordination complexes
10/24/2007EP1845993A2 Novel adenosine a3 receptor modulators
10/24/2007EP1845990A2 Treatment of metastasized tumors
10/24/2007EP1845984A2 Methylphenidate derivatives and uses of them
10/24/2007EP1845975A1 Combinations of pyrazole kinase inhibitors and further antitumor agents
10/24/2007EP1845974A1 Pharmaceutical compounds
10/24/2007EP1845973A1 Pharmaceutical compounds
10/24/2007EP1845966A1 Antineoplastic preparation and the use of antineoplastic preparation
10/24/2007EP1845963A2 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma
10/24/2007EP1845957A1 Method for producing a drug extract that contains hydroxystilbene
10/24/2007EP1658081B1 Immunosuppressive effects of pteridine derivatives
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1534710B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/24/2007EP1478784B1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/24/2007EP1478343A4 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
10/24/2007EP1287006B1 Antitumoral compounds
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
10/24/2007CN101061138A T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
10/24/2007CN101061114A Amide derivatives, their manufacture and use as pharmaceutical agents
10/24/2007CN101061112A (Spirocyclylamido) aminothiophene compounds as c-Kit proto-oncogene inhibitors
10/24/2007CN101061111A DNA-PK inhibitors
10/24/2007CN101061108A New 4-benzimidazolyl-3(2h)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
10/24/2007CN101061101A Aroylfuranes and aroylthiophenes suitable
10/24/2007CN101060886A Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
10/24/2007CN101060843A Quinolone analogs as cell proliferation inhibitors
10/24/2007CN101058815A Deletion mutant of a set of hepatitis B HBx gene and application thereof
10/24/2007CN101058809A Humanization modified rat ING4 gene and adenovirus expression vectors thereof
10/24/2007CN101058808A Breast cancer relevant p69 gene, coding protein and application thereof
10/24/2007CN101058609A Human antibody and expression thereof
10/24/2007CN101058604A FK gene, coding protein and application thereof
10/24/2007CN101058603A SIP45 gene, coding protein and application thereof
10/24/2007CN101058599A Application of thymidylate synthase mRNA used as tumour therapeutic agent for disturbing peptide
10/24/2007CN101058579A Camptothecin analogs and methods of preparation thereof
10/24/2007CN101058578A Dextrorotation deoxidization tylophorinine, preparation method thereof, pharmaceutical composition and use thereof
10/24/2007CN101058573A 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
10/24/2007CN101058572A Peptides compound with antineoplastic activity
10/24/2007CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy
10/24/2007CN101057964A Application of marasmius androsaceus glycoprotein in medicine making
10/24/2007CN101057945A Traditional Chinese medicine for treating digestive cancer and its producing method
10/24/2007CN101057913A New medical using of vitex and method for preparing medicinal intermediate
10/24/2007CN101057908A Heart and brain health dispersion tablet and its preparation method
10/24/2007CN101057888A Traditional Chinese medicinal composition for regulating immunity and its preparation method and application
10/24/2007CN101057886A Medicine for treating early bone tumor
10/24/2007CN101057883A Medicinal composition with anti tumor function
10/24/2007CN101057879A Microwave extraction method for total flavones of sacandra glabra
1 ... 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 ... 2211